Scale-up of integrated HIV services had reached the following number of sites:

• 751 static and 225 outreach HIV testing sites

• 739 (static) ART sites; 642 of these started at least one pregnant or breastfeeding woman and 712 started asymptomatic patients (Test & Treat) this quarter

• 676 sites with HIV-exposed children in follow-up

1,142,872 persons were tested for HIV and received their results; 293,291 (25%) accessed HIV testing for the first time; 892,501 (75%) were repeat testers and 44,335 (4%) of these received confirmatory testing (after having tested positive in the past). 38,048 (3.3%) clients received a positive result for the first time.

22,063 (98%) of 22,473 blood units collected were screened for (at least) HIV, hepatitis B and syphilis.

161,570 (96%) of 164,759 women at ANC had their HIV status ascertained; 12,203 (8%) of these were HIV positive. 144,710 (99%) of 145,576 women at maternity had their HIV status ascertained 10,583 (7%) of these were HIV positive.

35,277 patients started ART this quarter; 62% were classified as asymptomatic / in WHO stage 1 and started under the new “Test & Treat” policy.

767,452 patients were alive and on ART by end of March 2018. This means that 73% of the estimated 1,055,000 HIV positive population was on ART. ART coverage was 67% (46,186 / 69,000) for children and 73% (721,266 / 986,000) for adults.

61,237 (86%) of 70,830 viral load results from routine monitoring were <1000 copies/ml. Viral suppression rates for routine samples among children (0-14 years) and adults (15+ years) were 55% and 89%, respectively.

75% of adults and 75% of children were retained alive on ART at 12 months after initiation.

664,458 (89%) of 743,818 patients on first line adult ART were on TDF/3TC/EFV.

13,327(95%) of an estimated 14,000 HIV infected pregnant women in Malawi were on ART this quarter. 9,051 (68%) of these were already on ART when getting pregnant and 4,276 (32%) started ART during pregnancy/delivery.

An additional 1,707 breastfeeding women started ART in WHO stage 1 or 2.

79%, 74%, 68% and 63% of women started while pregnant or breastfeeding were retained on ART at 6, 12, 24 and 36 months after initiation, respectively.

9,801 (7%) of infants discharged alive from maternity were known to be HIV exposed, 9,348 (95%) of these received ARV prophylaxis (nevirapine). 11,796 were enrolled in exposed child follow-up before age 2 months.

A total of 15,177 HIV exposed children were newly enrolled for follow-up this quarter.